Background-Angina symptoms have been reported to predict mortality in men. The aim of this study was to investigate the association between angina symptoms and mortality in women. Methods and Results-In 2004, 873 older participants in the Australian Longitudinal Study on Women's Health with self-reported ischemic heart disease participated in a nested substudy. Women were 77 to 83 years of age; 165 (19%) died during the 4.5-year follow-up. Angina symptoms were established with Seattle Angina Questionnaire (SAQ) scores for physical limitation, angina frequency, angina stability, and disease perception. Proportional hazards modeling was used to examine the relationship of SAQ score differences with mortality. Physical limitation scores were associated with mortality, with hazard ratios of 1.1, 1.9, and 3.4 for mild, moderate, and severe versus minimal limitations, respectively (PϽ0.001). Angina frequency scores were also associated with death, with hazard ratios of 1.2, 1.2, and 4.8 for mild, moderate, and severe versus minimal angina frequency, respectively (PϽ0.001). Age (hazard ratio 1.1, 95% confidence interval 1.0 to 1.2), pulmonary disease (hazard ratio 1.6, 95% confidence interval 1.2 to 2.3), and kidney disease (hazard ratio 1.7, 95% confidence interval 1.1 to 2.5) were statistically significantly associated with mortality in a multivariable model of clinical predictors. In a combined model with SAQ scores and clinical predictors, SAQ scores for physical limitation and angina stability remained statistically significantly associated with mortality. Conclusions-In older women with ischemic heart disease, angina symptoms assessed by use of SAQ scores for physical limitations and angina frequency were associated with mortality; SAQ scores may therefore prove to be a useful tool for risk assessment in this patient group. (Circulation. 2009;120:2330-2336.)
I schemic heart disease (IHD) is a leading cause of death for men and women in Australia, as well as most other industrialized nations. Although IHD-related death rates for men and women are comparable, there are significant gender differences in the presentation and prognoses of IHD. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Compared with men, women are more likely to present with angina and less likely to present with recognized or unrecognized myocardial infarction. 1 Women with IHD have lower pain thresholds and report more frequent chest pain during daily life than men, 6 but among patients presenting with angina, women are less at risk than men for myocardial infarction and overall mortality. 1 Among women with angina, however, coronary mortality is higher than among women in the general population: Angina in women can by no means be discarded as a benign diagnosis. 11 Although in many women, persistent chest pain is reported in the absence of obstructive coronary artery disease, it is nevertheless predictive of adverse cardiovascular outcomes. 12 Besides biological gender differences in the progression of IHD, there are gender differences in the management of angina: Women are less likely to be referred for functional testing for ischemia or for revascularization procedures. 9
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The association between angina symptoms and mortality has been investigated previously with use of the Seattle Angina Questionnaire (SAQ), 13, 14 a self-administered instrument that measures 5 clinically important dimensions of health in patients with coronary artery disease. 15, 16 In a predominantly male population (patients within the US Veterans Affairs health system), angina symptoms have been reported to predict mortality. 13, 14 A previous study that used the SAQ in a mixed population of men and women showed that compared with men, women reported greater physical limitation related to angina pain. 7 The aim of the present study was to investigate the association between angina symptoms and mortality in older women. Angina symptoms were assessed with SAQ scores for physical limitation, angina frequency, angina stability, and disease perception.
Methods

Study Design and Population
This project is a nested prospective substudy of the Australian Longitudinal Study on Women's Health (ALSWH), which recruited more than 40 000 women in 3 age cohorts (born in 1973 to 1979, 1946 to 1951, and 1921 to 1926) from all parts of Australia. Women were randomly selected from the Australian Medicare database in 1996, with intentional oversampling in rural and remote areas. 17 The Medicare database includes all citizens and permanent residents. This project is based on the cohort born in 1921 to 1926 who were followed up with surveys every 3 years. The flow of women included in the present analysis is shown in Figure 1 . In 2004, 1500 ALSWH participants were selected among women who had not previously participated in an ALSWH substudy, who participated in survey 3 in 2001, and who answered "yes" to at least 1 of the following questions: "Have you ever been told by a doctor that you have heart disease?" in survey 1 (1996) ; "in the last 3 years, have you been told by a doctor that you have heart disease (including angina, heart attack)?" in survey 2 (1999); or "in the last 3 years, have you been diagnosed with or treated for angina/heart attack/other heart problems?" in survey 3 (2002) . These women were sent a written invitation and a cardiac-focused survey. Those not responding were contacted by phone and encouraged to complete the survey. Those unwilling to complete the postal survey were offered the option of completing it over the phone. Among the women who completed and returned the survey, for the present analyses, women with IHD were selected on the basis of affirmative answers to survey questions about angina, previous myocardial infarction, or having undergone coronary revascularization procedures. Both the ALSWH main study and the nested substudy were approved by ethics committees of the Universities of Newcastle and Queensland.
Health Status and Sociodemographics
All sociodemographic and health status data were obtained through self-reported survey questions. Angina symptoms were assessed with the SAQ, a valid and reliable measure of angina severity. 15, 16 The SAQ consists of 19 items that quantify 5 domains of angina: Physical limitation, angina stability, angina frequency, treatment satisfaction, and perception of effects of angina on quality of life ("disease perception"). For the majority of questions, a 5-point Likert scale was used for patients to rate their angina symptoms, the impact of angina symptoms on daily activities and well-being, and their satisfaction with angina treatment over the previous 4 weeks. Responses typically range from "severely limited" to "not limited" or from "not satisfied at all" to "highly satisfied." The respondent could also indicate that she was limited or did not participate in the activity for reasons other than angina. The range of scores for these domains was 0 to 100, with higher scores indicating fewer symptoms and better quality of life. Physical limitation and angina frequency scores were classified as minimal (75 to 100), mild (50 to 74), moderate (25 to 49), or severe (0 to 24). Angina stability scores were classified as much better (76 to 100), slightly better (51 to 75), unchanged (50), slightly worse (25 to 49), or much worse (0 to 25). Disease perception scores were classified as excellent (75 to 100), good (50 to 74), fair (25 to 49), or poor (0 to 24). Clinical variables derived from survey questions included having doctor-diagnosed arthritis, pulmonary disease, thyroid disease, diabetes mellitus, hypertension, high cholesterol or high lipids, kidney problems, heart failure, and a history of myocardial infarction. There were also questions about previous angioplasty or coronary artery bypass graft procedures and past and present smoking habits. Sociodemographic variables were derived from ALSWH main survey questions. These were level of education, marital status, and ability to manage on available income. Additionally, area of residence was derived from postal address, based on ARIA Plus, a new version of the Accessibility/Remoteness Index of Australia. 18 The ALSWH main study includes the Short Form-36 (SF-36), a generic measure of health status. In the present analysis, SF-36 subscales derived from the ALSWH main study were used to compare the health status of substudy responders and nonresponders. Scores for physical functioning, bodily pain, general health, vitality, and mental health were calculated with SF-36 items according to standardized procedures. 19, 20 Items were positively scored so that higher scores represented better health.
Mortality Data
To ascertain survival status, ALSWH data were linked to the National Death Index maintained at the Australian Institute of Health and Welfare. The sensitivity of the National Death Index for identifying known deaths in the 1921 to 1926 cohort of the ALSWH is 95%. 21 The substudy commenced in July 2004, and follow-up of survival data for the present analyses ended in January 2009.
Statistical Analysis
Analyses were conducted with SAS software, version 9 (SAS Institute Inc, Cary, NC). Substudy responders were compared with nonresponders by survival (log-rank test), baseline sociodemographics ( 2 tests), and SF-36 scores in 2001 (survey 3 of the ALSWH main study). SF-36 subscale scores were compared with nonparametric tests (Kruskal-Wallis tests). Kaplan-Meier curves were computed for survival over 4.5 years, stratified by SAQ scores. To assess possible differences between women with and without physical limitation score data, the women were compared in terms of sociodemographic and clinical variables. Cox proportional hazard models were used to estimate the risk of death associated with SAQ domains, sociodemographic variables, and clinical variables. In a similar approach to that used by Spertus et al 13 models, 3 proportional hazards models were constructed. The first contained SAQ domain scores, and the second contained sociodemographic and clinical variables; the third model combined the first 2 models. Only variables significant in the univariate analysis at PϽ0.1 were included in the first and second models. To use all available data for modeling, a separate category for missing data was constructed for all relevant variables. To assess whether the missing data category might include observations that were disparate in terms of other important predictors, the 3 multivariable models were also fitted to multiply imputed data. 22, 23 Multiple imputation was conducted with PROC MI in SAS; each missing value was replaced by 5 simulated values. The imputation model contained sociodemographic, clinical, and SAQ data, as well as survival time. Cox proportional hazards modeling estimates from the imputation data sets were combined with PROC MIANALYZE in SAS. A sensitivity analysis was conducted that gave the modeling results with the multiply imputed data set and with data with separated categories for missing items.
Results
Of the 1500 women selected for the substudy, 1161 (77%) completed and returned the substudy questionnaire ("responders") and 339 (23%) did not ("nonresponders"; Figure  1 ). Responders were more likely than nonresponders to have a school or leaving certificate (68% versus 58%, PϽ0.001). They were not statistically significantly more likely to live in major cities (45% versus 41%, Pϭ0.21), to be married or living together (42% versus 38%, Pϭ0.22), or to find it "easy" or "not too bad" to manage on their available income (71% versus 68%, Pϭ0.39). Responders were in better health than nonresponders in terms of SF-36 subscales for physical functioning, general health, vitality, and mental health but not for bodily pain (Table 1) . Mortality was greater among nonresponders than responders (hazard ratio [HR] 2.52, 95% confidence interval [CI] 1.99 to 3.20, PϽ0.0001). Among the responders, there were 873 women (75%) who met our criteria for IHD ( Figure 1 ).
The mean age at the time of completion of the substudy was 81 years (SD 1.46, range 77 to 83 years). Baseline sociodemographic and clinical characteristics, as well as SAQ domain scores, are shown in Table 2 . Where applicable, the number of women with missing data is indicated. In further analyses, missing data were treated as a separate category if the numbers were sufficient to do so. For the 4 SAQ scores, there were few women in the least favorable category ("severe," "much worse," or "poor"), with percentages ranging from 1% to 9%. Missing data were relatively common, with the proportions ranging from one tenth to one fourth for the various SAQ scores.
During 4.5 years of follow-up, there were 165 deaths among the 873 women with IHD, or 48.7 deaths per 1000 person-years. Age, pulmonary disease, kidney disease, smoking status, and history of myocardial infarction were statistically significant predictors of death in the univariate analyses ( Figure 2 ). Of the SAQ scores, physical limitation and angina frequency were statistically significant predictors of death in the univariate analyses ( Figure 2 ). The strongest mortality predictor among the SAQ domains, the physical limitation score, is shown in a Kaplan-Meier curve in Figure 3 . There were no statistically significant differences between women with and without data for physical limitation in terms of sociodemographic and clinical characteristics.
Of the SAQ scores, low (severe) physical limitation and angina frequency scores were predictors of death in a multivariable proportional hazards model (Table 3 ). Of the sociodemographic and clinical variables, age, pulmonary disease, and kidney disease were predictors of death. When both models were combined, the SAQ scores were still statistically significant predictors of mortality in the presence of age and clinical predictors. Results of modeling with multiply imputed data were similar to results that used data with a separate category for missing data (Table 3 ).
Discussion
In older women with IHD, angina symptoms assessed with SAQ scores for physical limitations and angina frequency were associated with mortality. Lower scores, which signified more severe symptoms, were associated with greater mortality; the existence of missing data for the physical limitations score was also predictive of mortality.
Gender differences in the association between SAQ scores and mortality may be expected on the basis of gender differences in the presentation with acute coronary syndrome: Women are less likely than men to report chest pain or discomfort. 10 Age could contribute to the gender difference in presentation with acute coronary syndrome: Women with acute coronary syndrome are older than men with acute coronary syndrome, and age is associated with less reporting of chest pain. 10 The SAQ was previously reported by Spertus et al 13 to predict mortality in a predominantly male outpatient population. The present study in women differs from that conducted by Spertus et al 13 in several aspects, such as age (with a mean age of 81 [SD 1.5] versus 67 [SD 10] years) and setting (ALSWH participants with self-reported IHD versus outpatients within the US Veterans Affairs health system). The study by Spertus et al 13 included a greater number of participants (4484); however, only 79 of the participants were women, 13 compared with 873 women included in the present study. There were also differences in the distribution of SAQ scores in the 2 studies: In the study by Spertus et al, 13 a greater proportion of patients were in the "severe" category for physical limitation (15% versus 11%, differenceϭ4.0%, 95% CI 1.4% to 6.3%) and angina frequency (5% versus 2%, differenceϭ3.7%, 95% CI 2.4% to 4.7%). The present study, however, indicates that the finding by Spertus et al 13 (that patients' health status predicts subsequent mortality) holds true for older women. The proposed uses of the SAQ as a standardized end point for clinical trials, for risk adjustment in mortality models, and for identification of patients who are eligible for intervention in clinical practice are therefore also applicable for women. 13 The results of the present study are at odds with the results of a prospective population study in middle-aged Finnish men and women 24 : Typical chest pain was found to be a predictor of mortality in men but not in women. The difference with the present findings could be due to a difference in subject age: Women were 30 to 59 years old, with a 5-year mortality follow-up, in the Finnish study 24 compared with 77 to 83 years with a 4.5-year follow-up in the present study. Overall 5-year mortality in these relatively young women was low (0.9%). Furthermore, the authors suggest that high cardiovas- cular mortality of nonattendant women may have decreased the association between pain symptoms and mortality.
The results of the present study are consistent with previous findings that exertional chest pain was predictive of coronary heart disease mortality in women and men. 11, 25 In women, exertional chest pain was found to be weakly associated with total mortality (HR 1.4, 95% CI 1.0 to 1.9) and strongly associated with coronary heart disease mortality (2.7, 95% CI 1.7 to 4.2), but it was not associated with noncoronary mortality (1.0, 95% CI 0.7 to 1.5). 25 The present study does not distinguish between causes of death, but we would expect the SAQ to be more strongly predictive of coronary death than of overall mortality.
Of the clinical and demographic variables examined, we found smoking, kidney disease, pulmonary disease, heart failure, and history of myocardial infarction but not diabetes mellitus to be associated with mortality in women with IHD. This is surprising, because both all-cause mortality and cardiovascular deaths have been found to be increased among women with diabetes mellitus and coronary heart disease compared with women with coronary heart disease only. 26 Participants in the study by Hu et al 26 were considerably younger than those in the present study; their initial ages were 30 to 55 years, with a follow-up of 20 years. This may explain the difference in findings, in that a number of women with diabetes and IHD may have died before reaching the age for inclusion in the present study (healthy-survivor effect). Although diabetes is common in old age, its prevalence decreases in the very elderly. 27 Diabetes (with or without IHD) may not be as strong a predictor of death in older women as it is in younger ones. The reported association between angina, clinical predictors, and mortality in the present study is limited to older women.
Missing data in the SAQ score for physical limitation were associated with higher mortality risk. Whether the increased mortality among this group was due to IHDrelated deaths or to other causes remains to be elucidated. It would appear prudent, however, not to exclude these women from analyses because they differ from other women in terms of mortality.
The strengths of the present study are its wealth of data: As a nested substudy of the ALSWH, an additional range of participant information was available, such as sociodemographics and SF-36 scores, as well as linkage to the National Death Index to ensure reliable mortality data. ALSWH participants were selected from the national health insurance database, which includes all citizens and permanent residents. 17 Because inclusion in the nested substudy was based on self-reported heart disease, eligible women were not restricted to a specific district, medical practice, or type of insurance. Substudy participants were not, however, a random selection of ALSWH participants with IHD: Women who were invited to participate but did not respond had less education, were in poorer health, and died sooner. The present findings are therefore limited to relatively healthy and educated older Australian women. Finally, the present study is limited by its absence of clinical data; all medical information is derived from survey questions and is therefore subject to error.
In summary, among older women with IHD, angina symptoms are associated with mortality. The SAQ scores for physical limitation and angina frequency could there- fore provide a useful tool for risk assessment in older women, but applicability to younger women remains to be established.
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